Cabaletta Bio Inc
CABA
Get informed when a big investor buys or sells
+ FollowMarket Cap$510.36M
Close$
$0.55
81.2% downside
Current Fair Value
81.2% downsideOvervalued by 81.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $510.36 Million |
|---|---|
| Enterprise Value | $310.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.64 |
| Beta | 3.25 |
| Outstanding Shares | 151,160,280 |
Return
| Return on Equity | -86.10% |
|---|---|
| Return on Assets | -70.63% |
| Return on Invested Capital | -86.17% |
Valuation & Multiples
| P/E Ratio | -1.98 |
|---|---|
| PEG | -15.18 |
| Price to Sales | - |
| Price to Book Ratio | 2.91 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.66 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
$1.67 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$1.67 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0659▲ 0.11% |
|---|---|
| Total Calls | 2,226,800▲ 67.27% |
| Total Puts | 146,700▲ 69.99% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 75.59%▲ 1.03% |
|---|---|
| Total Invested | $227.51M▲ 36.29% |
| Investors Holding | 118▲ 20.00% |
ESG Score
No data